Mucins are heavily glycosylated proteins, which are synthesized and secreted by epithelial cells lining the gastrointestinal, respiratory and genitourinary tracts. To date, thirteen distinct mucin genes have been identified and these can be divided into two distinct classes, gel-forming mucins and membrane-bound mucins. In salivary secretions, mucins facilitate speech and swallowing, protect oral surfaces against microbial, chemical and mechanical injury and contribute to a selectively permeable diffusion barrier between underlying surfaces and the external environment. These functions have largely been attributed to the major gel-forming mucin in saliva, MG1. Nevertheless, we have recently shown that two membrane-bound mucins, MUC1 and MUC4, are expressed in all major salivary glands, including the parotid glands. While virtually nothing is known about the expression and functional properties of membrane-bound mucins in salivary glands and saliva, our hypothesis is that these molecules form an integral part of the oral host-defense system in the protection of oral epithelial surfaces. The overall goal of this project is to understand the mechanisms by which this occurs.
The Specific Aims of this project are to: 1) determine the expression pattern of the membrane-bound mucins MUC1 and MUC4 in major and minor salivary glands and in different glandular secretions. 2) characterize the nature of the interactions between membrane-bound and gel-forming mucins and 3) investigate the role of MUC I and MUC4 in protection of oral epithelial surfaces from microbial attack.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
1R01DE014080-01A2
Application #
6544926
Study Section
Special Emphasis Panel (ZRG1-OBM-1 (01))
Program Officer
Kousvelari, Eleni
Project Start
2002-08-01
Project End
2005-07-31
Budget Start
2002-08-01
Budget End
2003-07-31
Support Year
1
Fiscal Year
2002
Total Cost
$241,500
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Oppenheim, Frank G; Helmerhorst, Eva J; Lendenmann, Urs et al. (2012) Anti-candidal activity of genetically engineered histatin variants with multiple functional domains. PLoS One 7:e51479
Komatsu, Tomoko; Salih, Erdjan; Helmerhorst, Eva J et al. (2011) Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry. J Proteome Res 10:646-55
Li, Xiaojing; Wang, Li; Nunes, David P et al. (2005) Suppression of MUC1 synthesis downregulates expression of the epidermal growth factor receptor. Cancer Biol Ther 4:968-73
Yeshwant, Krishna; Seldin, Edward B; Gateno, Jaime et al. (2005) Analysis of skeletal movements in mandibular distraction osteogenesis. J Oral Maxillofac Surg 63:335-40
Bruno, Lucila S; Li, Xiaojing; Wang, Li et al. (2005) Two-hybrid analysis of human salivary mucin MUC7 interactions. Biochim Biophys Acta 1746:65-72
Soares, Rodrigo V; Lin, Thomas; Siqueira, Camille C et al. (2004) Salivary micelles: identification of complexes containing MG2, sIgA, lactoferrin, amylase, glycosylated proline-rich protein and lysozyme. Arch Oral Biol 49:337-43
Becerra, Laura; Soares, Rodrigo V; Bruno, Lucila S et al. (2003) Patterns of secretion of mucins and non-mucin glycoproteins in human submandibular/sublingual secretion. Arch Oral Biol 48:147-54
Soares, R V; Siqueira, C C; Bruno, L S et al. (2003) MG2 and lactoferrin form a heterotypic complex in salivary secretions. J Dent Res 82:471-5
Li, X; Wang, L; Nunes, D P et al. (2003) Pro-inflammatory cytokines up-regulate MUC1 gene expression in oral epithelial cells. J Dent Res 82:883-7